SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J Y Soh, M Thalayasingam, S Ong, E X L Loo, L P Shek, S S Chao, Sublingual immunotherapy in patients with house dust mite allergic rhinitis: prospective study of clinical outcomes over a two-year period, The Journal of Laryngology & Otology, 2016, 1

    CrossRef

  2. 2
    Stefano Miceli Sopo, Andrea Battista, Monica Greco, Serena Monaco, Grass pollen sublingual immunotherapy and paediatric allergic rhinitis: A patient-oriented decision, Allergologia et Immunopathologia, 2015,

    CrossRef

  3. 3
    Oliver Pfaar, Roy Gerth van Wijk, Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?, Current Treatment Options in Allergy, 2015, 2, 1, 1

    CrossRef

  4. 4
    Nerin N Bahceciler, Arzu Babayigit Hocaoglu, Nilufer Galip, A milestone in house dust-mite-allergen immunotherapy: the new sublingual tablet S-524101 (actair), Expert Review of Vaccines, 2014, 13, 12, 1427

    CrossRef

  5. 5
    Stephanie Hofmaier, Allergic airway diseases in childhood: An update, Pediatric Allergy and Immunology, 2014, 25, 8
  6. 6
    Moises A. Calderon, Linda S. Cox, Monoallergen Sublingual Immunotherapy Versus Multiallergen Subcutaneous Immunotherapy for Allergic Respiratory Diseases: A Debate During the AAAAI 2013 Annual Meeting in San Antonio, Texas, The Journal of Allergy and Clinical Immunology: In Practice, 2014, 2, 2, 136

    CrossRef

  7. 7
    Aarif O Eifan, Moises A Calderon, Stephen R Durham, Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma, Expert Opinion on Biological Therapy, 2013, 13, 11, 1543

    CrossRef

  8. 8
    Moises A. Calderon, Thomas B. Casale, Harold S. Nelson, Pascal Demoly, An evidence-based analysis of house dust mite allergen immunotherapy: A call for more rigorous clinical studies, Journal of Allergy and Clinical Immunology, 2013, 132, 6, 1322

    CrossRef

  9. 9
    Heleen Moed, Roy Gerth van Wijk, Rudi W. Hendriks, J. C. van der Wouden, Evaluation of Clinical and Immunological Responses: A 2-Year Follow-Up Study in Children with Allergic Rhinitis due to House Dust Mite, Mediators of Inflammation, 2013, 2013, 1

    CrossRef

  10. 10
    Désirée Larenas-Linnemann, Michael Blaiss, Hugo P. Van Bever, Enrico Compalati, Carlos E. Baena-Cagnani, Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009-2012, Annals of Allergy, Asthma & Immunology, 2013, 110, 6, 402

    CrossRef

  11. 11
    Menno A. Kiel, Esther Röder, Roy Gerth van Wijk, Maiwenn J. Al, Wim C.J. Hop, Maureen P.M.H. Rutten-van Mölken, Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy, Journal of Allergy and Clinical Immunology, 2013, 132, 2, 353

    CrossRef

  12. 12
    Metin Aydogan, Aarif O. Eifan, Sevgi Keles, Tunc Akkoc, Mustafa A. Nursoy, Nerrin N. Bahceciler, Isil B. Barlan, Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: A double-blind-placebo-controlled randomised trial, Respiratory Medicine, 2013, 107, 9, 1322

    CrossRef

  13. 13
    C. de Bot, H. Moed, M. Berger, E. Röder, W. Hop, H. de Groot, J. de Jongste, R. G. van Wijk, P. Bindels, J. C. van der Wouden, Reply, Pediatric Allergy and Immunology, 2012, 23, 4
  14. 14
    Claus Bachert, G. Walter Canonica, Albrecht Bufe, SIT: efficacy depends on product, not on route of application, Pediatric Allergy and Immunology, 2012, 23, 4